Preoperative 18[F]-fluorodeoxyglucose positron emission tomography/computed tomography predicts early recurrence after pancreatic cancer resection

[1]  Y. Nishimura,et al.  Intraoperative radiotherapy for unresectable pancreatic cancer: a multi-institutional retrospective analysis of 144 patients. , 2010, International journal of radiation oncology, biology, physics.

[2]  G. Storme,et al.  Can 18F-FDG-PET response during radiotherapy be used as a predictive factor for the outcome of head and neck cancer patients? , 2010, Nuclear medicine communications.

[3]  A. Shields,et al.  F-Fluorodeoxyglucose Positron Emission Tomography to Monitor Clinical Outcomes in Patients Treated With Neoadjuvant Chemo-Radiotherapy for Locally Advanced Pancreatic Cancer , 2010 .

[4]  Y. Nishimura,et al.  Intraoperative radiotherapy for resected pancreatic cancer: a multi-institutional retrospective analysis of 210 patients. , 2010, International journal of radiation oncology, biology, physics.

[5]  T. Hyslop,et al.  Does Intraoperative Radiation Therapy Improve Local Tumor Control in Patients Undergoing Pancreaticoduodenectomy for Pancreatic Adenocarcinoma? A Propensity Score Analysis , 2009, Annals of Surgical Oncology.

[6]  Kanji Takahashi,et al.  Surgical Results After Preoperative Chemoradiation Therapy for Patients With Pancreatic Cancer , 2009, Pancreas.

[7]  E. Hatano,et al.  Contribution of 18F-fluorodeoxyglucose positron emission tomography to the diagnosis of early pancreatic carcinoma. , 2008, Journal of hepato-biliary-pancreatic surgery.

[8]  R. Bold,et al.  Preoperative evaluation of pancreatic adenocarcinoma. , 2008, Journal of hepato-biliary-pancreatic surgery.

[9]  S. Yachida,et al.  Role of 18F-fluorodeoxyglucose positron emission tomography imaging in surgery for pancreatic cancer. , 2008, World journal of gastroenterology.

[10]  Kanji Takahashi,et al.  Neoadjuvant Chemoradiation in Patients With Potentially Resectable Pancreatic Cancer , 2008, Pancreas.

[11]  V. Heinemann,et al.  Primary advanced unresectable pancreatic cancer. , 2008, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

[12]  K. Hirata,et al.  Surgery versus radiochemotherapy for resectable locally invasive pancreatic cancer: Final results of a randomized multi-institutional trial , 2008, Surgery Today.

[13]  M. Schwaiger,et al.  Prediction of tumor response by FDG-PET: comparison of the accuracy of single and sequential studies in patients with adenocarcinomas of the esophagogastric junction , 2007, European Journal of Nuclear Medicine and Molecular Imaging.

[14]  Peter Neuhaus,et al.  Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: a randomized controlled trial. , 2007, JAMA.

[15]  S. Jinnouchi,et al.  Role of positron emission tomography in decisions on treatment strategies for pancreatic cancer. , 2006, Journal of hepato-biliary-pancreatic surgery.

[16]  V. Heinemann,et al.  Chemoradiotherapy with gemcitabine and continuous 5-FU in patients with primary inoperable pancreatic cancer. , 2006, JOP : Journal of the pancreas.

[17]  S. Larson,et al.  Preoperative 18[F]-fluorodeoxyglucose positron emission tomography standardized uptake values predict survival after esophageal adenocarcinoma resection. , 2006 .

[18]  J. Lee,et al.  Different glucose uptake and glycolytic mechanisms between hepatocellular carcinoma and intrahepatic mass-forming cholangiocarcinoma with increased (18)F-FDG uptake. , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[19]  R. Cerfolio,et al.  The maximum standardized uptake values on positron emission tomography of a non-small cell lung cancer predict stage, recurrence, and survival. , 2005, The Journal of thoracic and cardiovascular surgery.

[20]  W. Oyen,et al.  FDG-PET is able to detect pancreatic carcinoma in chronic pancreatitis , 2005, European Journal of Nuclear Medicine and Molecular Imaging.

[21]  M. Imamura,et al.  A randomized multicenter trial comparing resection and radiochemotherapy for resectable locally invasive pancreatic cancer. , 2004, Surgery.

[22]  S. Larson,et al.  Preoperative F-18 fluorodeoxyglucose-positron emission tomography maximal standardized uptake value predicts survival after lung cancer resection. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[23]  C. Pinson,et al.  Pancreatic tumors: role of imaging in the diagnosis, staging, and treatment. , 2004, Journal of hepato-biliary-pancreatic surgery.

[24]  T. Saga,et al.  Relationship between retention index in dual-phase (18)F-FDG PET, and hexokinase-II and glucose transporter-1 expression in pancreatic cancer. , 2002, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[25]  R. Yamada,et al.  Diagnostic usefulness of FDG PET for pancreatic mass lesions , 2001, Annals of nuclear medicine.

[26]  P. Dupont,et al.  Prognostic importance of the standardized uptake value on (18)F-fluoro-2-deoxy-glucose-positron emission tomography scan in non-small-cell lung cancer: An analysis of 125 cases. Leuven Lung Cancer Group. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[27]  N. Tamaki,et al.  Expression of glucose transporters in human pancreatic tumors compared with increased FDG accumulation in PET study. , 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[28]  H. Friess,et al.  2-(fluorine-18)-fluoro-2-deoxy-D-glucose PET in detection of pancreatic cancer: value of quantitative image interpretation. , 1995, Radiology.

[29]  H. Friess,et al.  Diagnosis of pancreatic cancer by 2[18F]-fluoro-2-deoxy-D-glucose positron emission tomography. , 1995, Gut.